MEP Barry Andrews, on behalf of the Committee on Development, has submitted a parliamentary question to the European Commission seeking details on how its global health resilience initiative will safeguard public health priorities in partner countries amid cuts in global health funding. The question, dated 8 June 2026, presses the Commission on five specific areas: health sovereignty and local manufacturing, countering health disinformation, policy coherence across trade and intellectual property, gender disparities in health, and the initiative's implementation plan and budget.
Andrews requests a clear roadmap and accountability framework, as well as the budgetary envelope under the next multiannual financial framework. He also demands that commercial interests do not override public health priorities or undermine local capacity, signaling concern over private sector influence.
Policy orientations from the question point toward strengthening country-led, equitable health systems, with emphasis on universal access to sexual and reproductive health services and addressing gender-based violence. The MEP also calls for ensuring that EU trade and intellectual property policies do not hinder access to health technologies.
The Commission is required to reply within approximately six weeks. The answer will indicate whether the initiative will include binding commitments, dedicated funding, and mechanisms to balance private investment with public health goals. Stakeholders impacted include partner country governments, local health manufacturers, women and children in developing countries, and EU pharmaceutical and health technology companies.